1. Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany;
2. Institute of Molecular Medicine, Ulm University, Ulm, Germany;
3. TUM, School of Medicine, Clinical Chemistry and Pathobiochemistry, Munich, Germany;
4. Human Biology and BioImaging, Faculty of Biology, Ludwig-Maximilians-Universität München, Munich, Germany;
5. Institute of Experimental and Clinical Cell Therapy, Paracelsus University Salzburg, Salzburg, Austria;
6. TUM, Institute for Medical Microbiology, Immunology and Hygiene, CyTUM-MIH, Munich, Germany;
7. Bone Marrow Failure and MDS Program, Dana Farber and Boston Children’s Hospital, Boston, MA;
8. Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH;
9. Cancer and Developmental Biology Laboratory, Center for Cancer Research, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD;
10. Department for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria; and
11. German Cancer Consortium (DKTK), Heidelberg, Germany